Castle Biosciences, Inc. (CSTL)
NASDAQ·Healthcare·Medical - Diagnostics & Research
$24.69
-1.18%
Mkt Cap $741.04M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Feb 26, 2026 | $79.89M | $87.01M | +8.91% | -$0.23 | -$0.08 | +65.22% | — | — |
| Q4 2025 Nov 3, 2025 | $80.38M | $83.04M | +3.31% | -$0.34 | -$0.02 | +94.12% | — | — |
| Q3 2025 Aug 4, 2025 | $68.00M | $86.19M | +26.75% | -$0.51 | $0.15 | +129.41% | — | — |
| Q2 2025 May 5, 2025 | $71.82M | $87.99M | +22.51% | -$0.08 | -$0.20 | -150.00% | — | — |
| Q1 2025 Feb 27, 2025 | $83.89M | $86.31M | +2.89% | -$0.04 | $0.32 | +900.00% | — | — |
| Q4 2024 Nov 4, 2024 | $80.58M | $85.78M | +6.46% | -$0.06 | $0.08 | +233.33% | — | — |
| Q3 2024 Aug 5, 2024 | $69.34M | $87.00M | +25.47% | -$0.27 | $0.31 | +214.81% | — | — |
| Q2 2024 May 2, 2024 | $66.20M | $72.97M | +10.23% | -$0.37 | -$0.09 | +75.68% | — | — |
| Q1 2024 Feb 28, 2024 | $56.28M | $66.12M | +17.48% | -$0.84 | -$0.10 | +88.10% | — | — |
| Q4 2023 Nov 2, 2023 | $50.68M | $61.49M | +21.34% | -$0.92 | -$0.26 | +71.74% | — | — |
| Q3 2023 Aug 2, 2023 | $44.19M | $50.14M | +13.46% | -$1.01 | -$0.70 | +30.69% | — | — |
| Q2 2023 May 3, 2023 | $42.53M | $42.04M | -1.16% | -$0.80 | -$1.10 | -37.50% | — | — |
| Q1 2023 Feb 28, 2023 | $37.12M | $38.34M | +3.29% | -$0.91 | -$0.78 | +14.29% | — | — |
| Q4 2022 Nov 2, 2022 | $34.76M | $37.01M | +6.49% | -$0.70 | -$0.77 | -10.00% | — | — |
| Q3 2022 Aug 8, 2022 | $28.37M | $34.84M | +22.80% | -$0.58 | -$0.06 | +89.66% | — | — |
| Q2 2022 May 9, 2022 | $25.23M | $26.85M | +6.42% | -$0.67 | -$0.80 | -19.40% | — | — |
| Q1 2022 Feb 28, 2022 | $23.74M | $25.04M | +5.48% | -$0.43 | -$0.25 | +41.86% | — | — |
| Q4 2021 Nov 8, 2021 | $23.65M | $23.48M | -0.74% | -$0.35 | -$0.47 | -34.29% | — | — |
| Q3 2021 Aug 9, 2021 | $18.92M | $22.76M | +20.29% | -$0.29 | -$0.34 | -17.24% | — | — |
| Q2 2021 May 10, 2021 | $28.76M | $22.81M | -20.69% | -$0.22 | -$0.17 | +22.73% | — | — |